buy on weakness

AVAX Tests $24 Support; Bullish MACD Suggests Buy on Weakness

I see Avalanche (AVAX) trading at $24 after a 5.44% pullback that is testing near-term support. I view the drop as risk-on weakness rather than a breakdown, given the context.

Technicals show bullish MACD momentum emerging, which suggests underlying strength and the possibility of a rebound if support holds. I’m watching for confirmation in price action and volume.

I would consider a buy-on-weakness approach around current levels, but only after confirming support holds and using disciplined risk management.

Source available for registered users Sign Up Free

Analysis

Price dropped to $24, testing nearby support, but the MACD is turning bullish, indicating momentum may be shifting back to buyers. Confirmation should come from a stable close above short-term support...

Recommendation

Consider a buy-on-weakness strategy near $24 if support holds, with tight stops below the support level and confirmation from price/volume and MACD signals.

Disclaimer

The Analysis and recommendations provided are for informational purposes only. Any investment decisions should be made at your own risk. Past performance is not indicative of future results. Always conduct your own research and consider consulting with a financial advisor before making any investment decisions.

You might also be interested in: